Related Experiment Video
Updated: Apr 2, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Structural Mechanism for Regulation of Bcl-2 protein Noxa by phosphorylation
Christine B Karim1, L Michel Espinoza-Fonseca1, Zachary M James1
1Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455.
Abstract:
We showed previously that phosphorylation of Noxa, a 54-residue Bcl-2 protein, at serine 13 (Ser13) inhibited its ability to promote apoptosis through interactions with canonical binding partner, Mcl-1. Using EPR spectroscopy, molecular dynamics (MD) simulations and binding assays, we offer evidence that a structural alteration caused by phosphorylation partially masks Noxa's BH3 domain, inhibiting the Noxa-Mcl-1 interaction. EPR of unphosphorylated Noxa, with spin-labeled amino acid TOAC incorporated within the BH3 domain, revealed equilibrium between ordered and dynamically disordered states. Mcl-1 further restricted the ordered component for non-phosphorylated Noxa, but left the pSer13 Noxa profile unchanged. Microsecond MD simulations indicated that the BH3 domain of unphosphorylated Noxa is housed within a flexible loop connecting two antiparallel β-sheets, flanked by disordered N- and C-termini and Ser13 phosphorylation creates a network of salt-bridges that facilitate the interaction between the N-terminus and the BH3 domain. EPR showed that a spin label inserted near the N-terminus was weakly immobilized in unphosphorylated Noxa, consistent with a solvent-exposed helix/loop, but strongly constrained in pSer13 Noxa, indicating a more ordered peptide backbone, as predicted by MD simulations. Together these studies reveal a novel mechanism by which phosphorylation of a distal serine inhibits a pro-apoptotic BH3 domain and promotes cell survival.
Insights
Phosphorylation of Noxa protein at Serine 13 (pSer13) inhibits apoptosis by altering its structure, blocking interaction with Mcl-1. This structural change promotes cell survival by masking the BH3 domain.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Noxa is a pro-apoptotic protein and a binding partner of Mcl-1.
- Phosphorylation of Noxa at Serine 13 (pSer13) was previously shown to inhibit its pro-apoptotic function.
Purpose of the Study:
- To elucidate the structural mechanism by which pSer13 inhibits Noxa's interaction with Mcl-1.
- To understand how phosphorylation regulates Noxa's pro-apoptotic activity.
Main Methods:
- Electron Paramagnetic Resonance (EPR) spectroscopy with spin-labeled Noxa.
- Microsecond molecular dynamics (MD) simulations.
- Biochemical binding assays.
Main Results:
- Phosphorylation at Ser13 induces structural changes in Noxa, partially masking its BH3 domain.
- pSer13 alters the dynamic equilibrium of the BH3 domain, inhibiting Mcl-1 binding.
- MD simulations reveal salt-bridge formation in pSer13 Noxa, stabilizing the structure and sequestering the BH3 domain.
Conclusions:
- Phosphorylation of Noxa at Ser13 represents a novel regulatory mechanism controlling apoptosis.
- Structural alterations induced by phosphorylation inhibit the Noxa-Mcl-1 interaction, promoting cell survival.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Covalently Linked Protein Regulators
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

